Christopher P. Loo

1.2k citations

22 papers · 833 indexed · h-index 14

Impact in

Virology top 2%
- HIV Research and Treatment
Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Reproductive System and Pregnancy

Papers in ⓘ

Virology 8
- HIV Research and Treatment 8
Immunology 16
- Immune Cell Function and Interaction 13
- Reproductive System and Pregnancy 4
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4

Co-authors: Douglas F. Nixon (11 shared papers)Frederick Hecht (7 shared papers)Gerald Spotts (4 shared papers)Jakob Michaëlsson (6 shared papers)Joan M. Chapman (3 shared papers)Esper G. Kallás (4 shared papers)Amanda W. Lund (2 shared papers)Ryan S. Lane (2 shared papers)
Journals: PLoS ONE (3 papers)The Journal of Immunology (2 papers)The Journal of Infectious Diseases (2 papers)Journal of Tissue Engineering (1 paper)Journal of Leukocyte Biology (1 paper)
Partner nations: United States Sweden Brazil

In The Last Decade

Christopher P. Loo

22 papers receiving 822 citations

Peers

Countries citing papers authored by Christopher P. Loo

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Loo more than expected).

Fields of papers citing papers by Christopher P. Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Loo. The network helps show where Christopher P. Loo may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher P. Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher P. Loo Line = papers co-authored together Christopher P. Loo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin The Journal of Experimental Medicine ·Ryan S. Lane, Julia Femel, Alec P. Breazeale, Christopher P. Loo, Guillaume Thibault, Andy Kaempf, Motomi Mori, Takahiro Tsujikawa, Young Hwan Chang, Amanda W. Lund	2018	126
2	Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal PLoS ONE ·Fatema A. Legrand, Douglas F. Nixon, Christopher P. Loo, Érika Ono, Joan M. Chapman, Maristela Miyamoto, R. S. Díaz, Amélia Miyashiro Nunes dos Santos, Regina C.M. Succi, Jacob Abadi, Michael Rosenberg, Maria Isabel de Moraes‐Pinto, Esper G. Kallás	2006	114
3	Exploring Sponge-Derived Terpenoids for Their Potency and Selectivity against 12-Human, 15-Human, and 15-Soybean Lipoxygenases Journal of Natural Products ·Taro Amagata, Stephanie Whitman, Tyler A. Johnson, Chad C. Stessman, Christopher P. Loo, Emil B. Lobkovsky, Jon Clardy, Phillip Crews, Theodore R. Holman	2003	77
4	FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection Journal of Leukocyte Biology ·Lishomwa C. Ndhlovu, Christopher P. Loo, Gerald Spotts, Douglas F. Nixon, Frederick Hecht	2007	66
5	Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8⁺T_EMRACells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point Journal of Virology ·John Northfield, Christopher P. Loo, Jason D. Barbour, Gerald Spotts, Frederick Hecht, Paul Klenerman, Douglas F. Nixon, Jakob Michaëlsson	2007	64
6	Elevated Frequency of Gamma Interferon-Producing NK Cells in Healthy Adults Vaccinated against Influenza Virus Clinical and Vaccine Immunology ·Brian Long, Jakob Michaëlsson, Christopher P. Loo, Wassim Ballan, Bien‐Aimee N. Vu, Frederick Hecht, Lewis L. Lanier, Joan M. Chapman, Douglas F. Nixon	2007	56
7	Natural Killer Cells in Perinatally HIV-1-Infected Children Exhibit Less Degranulation Compared to HIV-1-Exposed Uninfected Children and Their Expression of KIR2DL3, NKG2C, and NKp46 Correlates with Disease Severity The Journal of Immunology ·Wassim Ballan, Bien‐Aimee N. Vu, Brian Long, Christopher P. Loo, Jakob Michaëlsson, Jason D. Barbour, Lewis L. Lanier, Andrew Wiznia, Jacobo Abadi, Glenn J. Fennelly, Michael Rosenberg, Douglas F. Nixon	2007	56
8	Individuals with Pulmonary Tuberculosis Have Lower Levels of Circulating CD1d‐Restricted NKT Cells The Journal of Infectious Diseases ·Jennifer Snyder‐Cappione, Douglas F. Nixon, Christopher P. Loo, Joan M. Chapman, Duncan A. Meiklejohn, Fernando Fiúza de Melo, Priscilla R. Costa, Johan K. Sandberg, Denise S. Rodrigues, Esper G. Kallás	2007	54
9	Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection Cell Reports ·Christopher P. Loo, Nicholas A. Nelson, Ryan S. Lane, Jamie L. Booth, Sofia C. Loprinzi Hardin, Archana Thomas, Mark K. Slifka, Jeffrey C. Nolz, Amanda W. Lund	2017	53
10	Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression AIDS ·Jennifer Snyder‐Cappione, Christopher P. Loo, Karina I. Carvalho, Carlotta Kuylenstierna, Steven G. Deeks, Frederick Hecht, Michael Rosenberg, Johan K. Sandberg, Esper G. Kallás, Douglas F. Nixon	2009	33
11	Immune Reconstitution of CD56^dimNK Cells in Individuals with Primary HIV‐1 Infection Treated with Interleukin‐2 The Journal of Infectious Diseases ·Jakob Michaëlsson, Brian Long, Christopher P. Loo, Lewis L. Lanier, Gerald Spotts, Frederick Hecht, Douglas F. Nixon	2007	22
12	Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus Journal of Tissue Engineering ·Iman K. Yazdi, Matthew B. Murphy, Christopher P. Loo, Xuewu Liu, Mauro Ferrari, Bradley K. Weiner, Ennio Tasciotti	2014	18
13	Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease Clinical & Experimental Immunology ·Lishomwa C. Ndhlovu, Jennifer Snyder‐Cappione, Karina I. Carvalho, Fábio E. Leal, Christopher P. Loo, Fernanda R. Bruno, Aashish R. Jha, Deborah DeVita, Aaron M. Hasenkrug, Hugo Marcelo Ribeiro Barbosa, Aluísio Augusto Cotrim Segurado, Douglas F. Nixon, Edward L. Murphy, Esper G. Kallás	2009	18
14	BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells Leukemia ·Kyle A. Romine, Kevin MacPherson‐Hawthorne, Hyun-Jun Cho, Yoko Kosaka, Patrick Flynn, Kaelan Byrd, Jesse L. Coy, Matthew Newman, Ravina Pandita, Christopher P. Loo, Jaime Scott, Andrew C. Adey, Evan Lind	2023	17
15	Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy PLoS ONE ·Satoko Matsueda, Mingjun Wang, Jinsheng Weng, Ying Li, Bingnan Yin, Jia Zou, Qingtian Li, Wei Zhao, Weiyi Peng, Xavier Legras, Christopher P. Loo, Rongfu Wang, Helen Y. Wang	2012	13
16	NK Cells and CD1d‐restricted NKT Cells Respond in Different Ways with Divergent Kinetics to IL‐2 Treatment in Primary HIV‐1 Infection Scandinavian Journal of Immunology ·Carlotta Kuylenstierna, Jennifer Snyder‐Cappione, Christopher P. Loo, Brian Long, Veronica D. Gonzalez, Jakob Michaëlsson, Markus Moll, Gerald Spotts, Frederick Hecht, Douglas F. Nixon, Johan K. Sandberg	2010	11
17	Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8+ T Cells: Implication for Cancer Immunotherapy PLoS ONE ·Mingjun Wang, Bingnan Yin, Satoko Matsueda, Lijuan Deng, Ying Li, Wei Zhao, Jia Zou, Qingtian Li, Christopher P. Loo, Rong‐Fu Wang, Helen Y. Wang	2013	9
18	Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines SHILAP Revista de lepidopterología ·C. A. Lundquist, Christopher P. Loo, Ismail M. Meraz, Jorge I. Cerdá, Xuewu Liu, Rita E. Serda	2014	8
19	Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN–Dependent Depletion of Dendritic Cells The Journal of Immunology ·Christopher P. Loo, Christopher M. Snyder, Ann B. Hill	2016	7
20	Nanostructured lipid carriers (NLC) for efficient delivery of palm phytonutrients Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) ·Christopher P. Loo, Rosnah Ismail, (unknown), Harrison Lik Nang Lau, Bimo Ario Tejo, (unknown), (unknown), M. S. Kanthimathi	2014	4

About Christopher P. Loo

Christopher P. Loo is a scholar working on Virology, Immunology, Dermatology, Toxicology and Ceramics and Composites, having authored 22 papers that have together received 833 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (8 papers), Reproductive System and Pregnancy (4 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphatic System and Diseases (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Virology (232 citations), Immunology (511 citations), Oncology (175 citations), Infectious Diseases (114 citations) and Toxicology (19 citations). Christopher P. Loo has collaborated with scholars based in United States, Sweden and Brazil. Frequent co-authors include Douglas F. Nixon, Frederick Hecht, Gerald Spotts, Jakob Michaëlsson, Joan M. Chapman, Esper G. Kallás, Amanda W. Lund, Ryan S. Lane, Michael Rosenberg and Brian Long. Their work appears in journals such as PLoS ONE, The Journal of Immunology, The Journal of Infectious Diseases, Journal of Tissue Engineering and Journal of Leukocyte Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact